1315 Capital
Philadelphia, Pennsylvania1315capital.com
Overview
1315 Capital is a private investment firm with over $1 billion of assets under management that provides expansion and growth capital to commercial-stage healthcare services, pharmaceutical & medical technology outsourcing, medical technology, and health & wellness companies . The firm targets both minority and majority investments in companies where high-quality management teams can rapidly scale platform companies into large and important businesses that positively impact patients, physicians, and the broader healthcare system .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Coating Place, Inc. | Jan 2026 | Growth Equity | Lead |
| Spineology | Aug 2024 | VC Round | Co-investor |
| Primrose Bio | Jun 2024 | VC Round | Lead |
| Biocoat Incorporated | Nov 2022 | Buyout/LBO | Co-investor |
| Nutrisense | Jul 2022 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.